Table 1. Results after prosthesis implant.
| VLRP patients (group B) | Diabetic and metabolic syndrome patients (group A) | P-value | |
|---|---|---|---|
| Patients, no. (%) | 96 (53.33) | 84 (46.67) | |
| Mean age, years ±s.d. | 66.4±4.9 | 59.2±10.5 | <0.05 |
| Marital status, no. (%) | |||
| Married | 84 (87.5) | 60 (71.43) | 0.13 |
| Single | 12 (12.5) | 24 (28.57) | 0.13 |
| Mean duration of ED before implant, months±s.d. | 24.5±18.6 | 74.5 ± 50.1 | <0.05 |
| Previous ED treatment, no. (%) | |||
| PDE5 inhibitor | 72 (75) | 60 (71.43) | 0.4 |
| ICI | 84 (87.5) | 42 (50) | <0.05 |
| Vacuum device | 30 (31.25) | 18 (21.43) | 0.27 |
| Intraoperative complications, no. (%) | 0 | 0 | - |
| Postoperative complications, no. (%) | |||
| Infections | 0 | 3 | 0.11 |
| Urethral erosion | 1 | 0 | 0.37 |
| Prosthesis extrusion | 0 | 1 | 0.37 |
| Mechanical failure | 0 | 0 | - |
| Scrotal hematoma | 6 (6.25) | 6 (7.14) | 0.46 |
Abbreviations: ED, erectile dysfunction; ICI, intracorpora injection; PDE5 inhibitor, phosphodiesterase type 5 inhibitor; VLRP, video-assisted laparoscopic radical prostatectomy. Values are expressed as mean±s.d. or number (percentage), where applicable.